Francis Collins to Retire as NIH Director by Year’s End

Collins has announced his intent to step down after leading the National Institutes of Health for more than 12 years.

Written byChristie Wilcox, PhD
| 3 min read
NIH Director Francis Collins receiving his first dose of the Moderna COVID-19 vaccine on December 22, 2020.

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

ABOVE: NIH Director Francis Collins receives his first dose of the Moderna COVID-19 vaccine on December 22, 2020.
FLICKR, NIH

Francis Collins, a physician and geneticist, was appointed as the 16th director of the National Institutes of Health in 2009 by then-President Barack Obama; his appointment was unanimously confirmed by the Senate, and he continued to lead the agency under presidents Donald Trump and Joe Biden. On Tuesday, the agency announced Collins will be stepping down by the end of the year.

In the NIH press release, Collins says it’s simply time: “It has been an incredible privilege to lead this great agency for more than a decade. . . . I fundamentally believe, however, that no single person should serve in the position too long, and that it’s time to bring in a new scientist to lead the NIH into the future.”

According to NPR, Collins has served longer than ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies